Business Standard

Sun Pharma aims for market share in all verticals amid Covid-19 situation

The drug major, which has presence in around 150 countries, caters to various various segments like psychiatry, anti-infectives, neurology, cardiology, oncology, among others

Sun Pharma
Premium

The Mumbai-based company also looks to focus on cash preservation and finding a way to reduce the overall debt for the company

Press Trust of India New Delhi
Drug major Sun Pharma aims to gain market share in all the verticals it is present in amid challenges posed by the coronavirus pandemic, as per a top company official.

"Our endeavour will be to gain market share in each of our business by doing better. Despite the near-term uncertainties related to Covid-19, we hope to be able to do better consistently," Sun Pharmaceutical Industries MD Dilip Shanghvi said in an analyst call.

The drug major, which has presence in around 150 countries, caters to various various segments like psychiatry, anti-infectives, neurology, cardiology, oncology, among others.

Shanghvi said that the

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jul 19 2020 | 3:30 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com